BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 32483662)

  • 1. Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinoma.
    Ha SY; Choi S; Park S; Kim JM; Choi GS; Joh JW; Park CK
    Virchows Arch; 2020 Dec; 477(6):807-816. PubMed ID: 32483662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of combined preoperative-postoperative neutrophil-to-lymphocyte ratio in predicting hepatocellular carcinoma prognosis after radiofrequency ablation.
    Ni Z; Wu B; Liu Z; Wang Q; Han X; Cheng W; Guo C
    Br J Radiol; 2023 Apr; 96(1145):20220887. PubMed ID: 36715151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
    Rich NE; Parvathaneni A; Sen A; Odewole M; Arroyo A; Mufti AR; Kerr TA; Grant L; Tujios SR; Mayo MJ; Lee WM; Yang JD; Yokoo T; Gopal P; Hoshida Y; Zhu H; Yopp AC; Marrero JA; Singal AG
    Dig Dis Sci; 2022 Jun; 67(6):2666-2676. PubMed ID: 33939138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis.
    Yao W; He JC; Yang Y; Wang JM; Qian YW; Yang T; Ji L
    Sci Rep; 2017 Aug; 7(1):7525. PubMed ID: 28790445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
    Qi X; Li J; Deng H; Li H; Su C; Guo X
    Oncotarget; 2016 Jul; 7(29):45283-45301. PubMed ID: 27304193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Xu C; Wu F; Du L; Dong Y; Lin S
    Front Immunol; 2023; 14():1211399. PubMed ID: 37809083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma.
    Imaoka K; Ohira M; Hattori M; Chogahara I; Sato S; Nakamura M; Bekki T; Sato K; Imaoka Y; Nakano R; Yano T; Sakai H; Kuroda S; Tahara H; Ide K; Kobayashi T; Tanaka Y; Ohdan H
    Transplant Proc; 2024 Apr; 56(3):634-639. PubMed ID: 38443302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
    Matsuda N; Yamamoto H; Habu T; Iwata K; Matsubara K; Tanaka S; Hashimoto K; Shien K; Suzawa K; Miyoshi K; Toji T; Okazaki M; Sugimoto S; Takahashi K; Toyooka S
    Ann Surg Oncol; 2023 Dec; 30(13):8727-8734. PubMed ID: 37658268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
    Ha SY; Choi M; Lee T; Park CK
    Cancer Res Treat; 2016 Jan; 48(1):180-9. PubMed ID: 25797572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection.
    Wang J; Chen Z; Wang L; Feng S; Qiu Q; Chen D; Li N; Xiao Y
    Sci Rep; 2022 May; 12(1):8670. PubMed ID: 35606395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes.
    Garcia-Torralba E; Pérez Ramos M; Ivars Rubio A; Navarro Manzano E; Blaya Boluda N; Lloret Gil M; Aller A; de la Morena Barrio P; García Garre E; Martínez Díaz F; García Molina F; Chaves Benito A; García-Martínez E; Ayala de la Peña F
    Breast Cancer Res Treat; 2024 Jun; 205(3):475-485. PubMed ID: 38453782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-lymphocyte ratio in relation to risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
    Thomas CE; Yu YC; Luu HN; Wang R; Paragomi P; Behari J; Yuan JM
    Cancer Med; 2023 Feb; 12(3):3589-3600. PubMed ID: 36052483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Neutrophil-to-Lymphocyte Ratio in Postmenopausal Breast Cancer Patients.
    Ijichi H; Tajiri W; Koi Y; Koga C; Nakamura Y; Okamoto M; Tokunaga E
    J Surg Res; 2024 Apr; 296():98-105. PubMed ID: 38266423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer.
    Iwata K; Suzawa K; Hashimoto K; Tanaka S; Shien K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
    Jpn J Clin Oncol; 2024 May; ():. PubMed ID: 38704243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-lymphocyte ratio reflects tumour-infiltrating lymphocytes and tumour-associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy.
    Li JJX; Ni SYB; Tsang JYS; Chan WY; Hung RKW; Lui JWH; Ng SWY; Shum LK; Tang YF; Tse GM
    Histopathology; 2024 Apr; 84(5):810-821. PubMed ID: 38192219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of the neutrophil‑to‑lymphocyte ratio during lenvatinib treatment for unresectable hepatocellular carcinoma.
    Kuwano A; Yada M; Koga Y; Tanaka K; Ohishi Y; Masumoto A; Motomura K
    Oncol Lett; 2024 Jul; 28(1):309. PubMed ID: 38784605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances.
    Wang X; Yuan Z; Li Z; He X; Zhang Y; Wang X; Su J; Wu X; Li M; Du F; Chen Y; Deng S; Zhao Y; Shen J; Yi T; Xiao Z
    Front Immunol; 2024; 15():1354313. PubMed ID: 38426090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and local immunosuppression in glioblastoma and its prognostic significance.
    Stepanenko AA; Sosnovtseva AO; Valikhov MP; Chernysheva AA; Abramova OV; Pavlov KA; Chekhonin VP
    Front Immunol; 2024; 15():1326753. PubMed ID: 38481999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflections: Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio are Prognostic Factors in Pulmonary Metastases from Uterine Leiomyosarcoma.
    Matsuda N; Yamamoto H; Habu T; Takahashi K; Toyooka S
    Ann Surg Oncol; 2023 Dec; 30(13):8757-8758. PubMed ID: 37648886
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic significance of systemic inflammatory parameters in high-grade glial tumor patients: Two center experience.
    Oztep Eskici S; Yilmaz EB
    Medicine (Baltimore); 2024 Apr; 103(16):e37726. PubMed ID: 38640334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.